Sahat Halim
Faculty of Medicine, Universitas Sumatera Utara, North Sumatra, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Respiratory Syncytial Virus Pneumonia in an Elderly Patient: A Case Report and Clinical Review Eric Daniel Tenda; Almerveldy Azaria Dohong; Sahat Halim; Alfino Syahputra; Muhammad Aziz Arridho
Indonesia Journal of Chest Critical Emergency Medicine Vol 13 No 1 (2026): Respiratory Syncytial VirusPneumoniain an Elderly Patient
Publisher : PERPARI (Perhimpunan Respirologi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection and is increasingly recognized as a clinically significant cause of pneumonia in older adults. However, RSV remains underdiagnosed in adult pneumonia because clinical and radiologic features overlap with bacterial pneumonia and other viral infections, and RSV testing is not routinely performed. Case: A 91-year-old man presented with one day of cough, low-grade fever, reduced appetite, generalized weakness, and acute delirium. On admission, he was hemodynamically stable with oxygen saturation 97–98% on room air. Initial laboratory tests showed elevated C-reactive protein (20.7 mg/L), mild lymphopenia, microcytic anemia (hemoglobin 10.0 g/dL), and mild hyponatremia (sodium 132 mEq/L). Chest radiography revealed bilateral pulmonary infiltrates. A multiplex acute respiratory infection PCR panel detected RSV type A, while other respiratory viruses and atypical bacterial pathogens were negative. On day 3 of hospitalization, he developed acute hypoxemia (SpO₂ 86–88% on room air) accompanied by a marked rise in inflammatory markers (CRP peak 148 mg/L; procalcitonin 0.44 ng/mL). He improved with supplemental oxygen, intravenous methylprednisolone, and a macrolide antibiotic, and was discharged in stable condition on day 7. Discussion: This case highlights RSV as an important and often overlooked etiology of community-acquired pneumonia in very old patients, including atypical presentations such as delirium and late clinical deterioration after an initially stable course. Molecular diagnostics (PCR-based panels) can provide timely etiologic confirmation, support infection control measures, and guide antimicrobial stewardship, particularly when bacterial co-infection is uncertain. Conclusion: RSV should be considered in elderly patients with pneumonia, especially during periods of respiratory virus circulation. Early molecular testing may improve diagnostic accuracy and optimize clinical management and prevention strategies in high-risk older adults. Keyword: respiratory syncytial virus; pneumonia; elderly; multiplex PCR; case report
Artificial Intelligence in Bronchoscopy for Pulmonary Disease: A Systematic Review of Randomized Controlled Trials Eric Daniel Tenda; Almerveldy Azaria Dohong; Nadia Iqbal; Aziza Harris; Steffi Cong Andi Nata; Muhammad Aziz Arridho; Alfino Syahputra; Sahat Halim
Indonesia Journal of Chest Critical Emergency Medicine Vol 13 No 1 (2026): Artificial Intelligence in Bronchoscopy for Pulmonary Disease: A Systematic Revi
Publisher : PERPARI (Perhimpunan Respirologi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Bronchoscopy is a core diagnostic and therapeutic procedure for pulmonary diseases, yet performance is highly operator dependent, contributing to variability in airway inspection completeness and procedural efficiency. Artificial intelligence (AI) systems have been developed to support real time airway anatomy recognition, navigation, and performance feedback. This systematic review summarizes randomized controlled trial evidence on the impact of AI guided bronchoscopy on procedural performance. Methods: This review followed PRISMA guidance and was registered in PROSPERO. We searched PubMed/MEDLINE, ScienceDirect, and SAGE Journals from database inception to January 2026. Two reviewers independently screened studies and extracted data. Risk of bias was assessed using the RoB 2 tool. Given heterogeneity in interventions, populations, and outcome definitions, results were synthesized narratively. Results: From 1,654 records, four randomized controlled trials met inclusion criteria. All studies were conducted in simulation settings and enrolled participants with varying experience (novice to experienced bronchoscopists, including critical care physicians). Overall, AI guided bronchoscopy favored AI supported groups compared with comparators (no AI, written instruction, directed self learning, or expert instruction), showing improvements in key performance domains such as inspection completeness and structured progression, as well as efficiency related metrics including intersegmental time and or total procedure time. Conclusion: Simulation based RCT evidence supports AI as a promising approach to improve standardization and procedural performance in bronchoscopy training. Multicenter patient based randomized trials are warranted to confirm benefits on clinically meaningful outcomes. Keywords: artificial intelligence; bronchoscopy; randomized controlled trial; simulation based training; procedural performance.